A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Filters
Open innovation and firms performance: state of the art and empirical evidences from the bio-pharmaceutical industry
2016
International Journal of Technology Management
Preserved Fulltext
The research presented in this paper explores the effect of inbound, outbound and coupled open innovation practices on firms' performances in the biopharmaceutical industry. ...
We state the importance for a manager to explore concurrently the influence of specific open innovation practices both on innovation and economic-financial performance. ...
Lichtenthaler (2009) addresses the relationship between outbound open R&D strategies, licensing-out among others, and firm performance; by using data from 136 industrial firms, his results show that a ...
doi:10.1504/ijtm.2016.075152
fatcat:xmwi3fsqifhe7pojn3ep5g67rq
Inbound and Outbound Practices of Open Innovation and Eco-Innovation: Contrasting Bioeconomy and Non-Bioeconomy Firms
2020
Journal of Open Innovation: Technology, Market and Complexity
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Overall, the empirical evidence allows the conclusion that inbound and outbound practices and public policies have a positive and significant influence on the eco-innovative performance of the firms studied ...
Specifically, it aims to analyse the effects of these practices on the eco-innovative performance of bioeconomy and non-bioeconomy firms, using secondary data gathered from the Community Innovation Survey—CIS ...
Despite the empirical evidence of a positive influence of knowledge from institutional sources on innovation, only Marzucchi and Montresor [84] and Del Río et al. ...
doi:10.3390/joitmc6040145
fatcat:l77f7xvafjbytkgxanxtngw63i
The interplay between new technology based firms, strategic alliances and open innovation, within a regional systems of innovation context. The case of the biotechnology cluster in Belgium
2015
Journal of Global Entrepreneurship Research
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
There is absence of studies that look at strategic partnershipsand specifically the role of open innovationin the development of small and innovative biotechnology firms. ...
In this article, we examine the impact of strategic partnerships and open innovation on the success of new biotechnology firms in Belgium by developing multiple case studies of firms in regional biotechnology ...
The basic innovative activity occurs mainly in university-based new biotechnology firms,(i.e., new, small firms that are spin-offs from university research centres performing state-of-the-art research) ...
doi:10.1186/s40497-015-0034-7
fatcat:xski6jnderenzhatcgku3mapne
Direct and mediated ties to universities: "Scientific" absorptive capacity and innovation performance of pharmaceutical firms
2015
Strategic Organization
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
absorptive capacity, while only mediated ties are associated with greater innovative performance for firms with relatively low scientific absorptive capacity. ...
Drawing on patent and publication data in a panel of 33 vertically integrated pharmaceutical firms, we find that direct university collaboration is more beneficial for firms with relatively high scientific ...
We wish to thank Massimo Riccaboni for allowing us access to the Pharmaceutical Industry Database and ECOOM at KU Leuven for access to Thomson Reuters' Web of Knowledge. ...
doi:10.1177/1476127015604734
fatcat:ktgd4ptgjndwxjfdgazij43lni
Understanding the Mechanisms of Bridging Science and Technology Domains within Firms for Better Patent Performance
2013
Innovation and Supply Chain Management
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
They emphasize the importance of bridging scientists who are competent in both science and technology domains to translate the scientific competency of firms into better patent performance. ...
In the absence of conscious exploitation, mere presence of bridging scientists does not ensure translation of scientific competencies into better technological innovation. ...
Acknowledgments This project is funded by The National University of Singapore research project # R-535-000-006-133. ...
doi:10.14327/iscm.7.137
fatcat:cwobzdz5ynhabjzv6l7lcmktli
The Impact of Regulation-Driven Environmental Innovation on Innovation Success and Firm Performance
2010
Social Science Research Network
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Abstract The impact of environmental innovations on firm performance is ambiguous. ...
Using firm data from the German innovation survey, we find that both product and process innovations driven by environmental regulation generate similar success in terms of sales with new products and ...
The highest share of firms with innovations triggered by environmental regulation can be found in the chemicals and pharmaceuticals industry (13 percent of all firms). ...
doi:10.2139/ssrn.1692616
fatcat:pau2zl2jpzedndxzhbn6khva3u
The Impact of Regulation-Driven Environmental Innovation on Innovation Success and Firm Performance
2011
Industry and Innovation
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Abstract The impact of environmental innovations on firm performance is ambiguous. ...
Using firm data from the German innovation survey, we find that both product and process innovations driven by environmental regulation generate similar success in terms of sales with new products and ...
The highest share of firms with innovations triggered by environmental regulation can be found in the chemicals and pharmaceuticals industry (13 percent of all firms). ...
doi:10.1080/13662716.2011.561027
fatcat:62lfrvoabvgujgktqipv3uhddu
Hidden Costs and the Role of Modularity: A Study on Offshoring Process Performance
2013
Academy of Management Proceedings
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
These 'born global' firms have survived through the dot-com crisis of 2000 and the global financial crisis of 2008 and continue to grow. ...
We investigate the key factors affecting the post-entry survival of these NIVs using in-depth analysis of seven 'born global' software firms originating from a peripheral economy-Pakistan. ...
VC Experience Elisa Alvarez-Garrido, Georgia State University There is empirical evidence that Venture capital (VC) firms foster innovation in the U.S. ...
doi:10.5465/ambpp.2013.16390abstract
fatcat:qgexsh5fkjawppojjmj744l7fu
HOW INTELLECTUAL PROPERTY RIGHTS ENCOURAGE PHARMACEUTICAL INNOVATION
2009
RAI: Revista de Administração e Inovação
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Substantial empirical research supports the utility of the Bayh-Dole model and doubts the existence of a patent anti-commons (editor note: the existence of numerous rights holders frustrates achieving ...
Clinical trials are performed in three phases and each phase results in a plethora of data. ...
Most radical-innovation pharmaceuticals have been invented in either the United States or Europe and a preponderance of the incremental-innovation pharmaceuticals as well (SCRIABINE, 1999) . ...
doi:10.5585/rai.v5i3.236
fatcat:eg4aaztoffhmflp6txkyi6sime
A new model of knowledge and innovative capability development for small born-global bio-tech firms: evidence from the East Midlands, UK
2015
International Journal of Entrepreneurship and Innovation Management
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
In science-based industries such as the biotechnology sector the ability to innovate can only occur if a firm is able to both generate and integrate knowledge from inside and outside its boundaries. ...
The newly developed framework is invaluable to researchers, small born-global bio-tech and large bio-pharmaceutical firms. ...
Empirical evidence from multiple cases of bio-tech firms, in the East Midlands region of the UK, is used to construct a new model of 'knowledge and innovative capability development'. ...
doi:10.1504/ijeim.2015.068421
fatcat:kiutxblh2bcj5euv3rwv72sp6i
Chinese expansion in the international healthcare markets: the role of Chinese OFDI in Europe
2017
International Journal of Healthcare Technology and Management
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
The paper sheds light on the increasing interest of Chinese firms operating in key healthcare (HC) industries into Europe. ...
After a description of the economic and policy context for HC in China, we perform an analysis on location choice by Chinese firms, updated to 2014, within Europe. ...
Acknowledgements The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme fp7/2007-2013/ under reA ...
doi:10.1504/ijhtm.2017.087591
fatcat:6v4a2pjzyzgg7new424w6fckzu
Benchmarking university–industry research cooperation worldwide: performance measurements and indicators based on co-authorship data for the world's largest universities
2009
Research Evaluation
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
The statistical data were derived from university-industry co-authored research publications (UICs) that were published during the years 2002-2006 and jointly authored by university researchers and staff ...
The results reveal a host of organizational variables that are likely to determine a university's UIC performance. ...
Acknowledgement The authors are grateful for Martijn Visser's valuable research assistance. ...
doi:10.3152/095820209x393145
fatcat:lcisd7xixnhmfdzbxkdkghbq7q
Transaction Costs and Organizational Competences: Explaining the Governance Structure for Manufacturing Stage
2012
Journal of Technology Management & Innovation
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
The study presents some methodological implications for applying the model in Brazilian pharmaceutical industry, through searching for secondary data on drugs and firms in a public database of the federal ...
power of the firm in the manufacturing stage, and "competences on operations", measured by experience and diversification of the firm. ...
The contribution of the study may be relevant for providing a research model adapted to the pharmaceutical industry, which is experiencing profound changes in technology and management. ...
doi:10.4067/s0718-27242012000100011
fatcat:b57bj7432rg4ldy5kjbomf4qky
Innovating routines in the business firm: what corporate tasks should they be accomplishing?
2002
Industrial and Corporate Change
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
combined with rich bodies of empirical evidence. ...
Background technologies
(Necessary for use of outside
technologies in supply chain and
pervasive applications)
1. Strong commitment of
technical resources to maintain
state of the art
OR
2. ...
doi:10.1093/icc/11.1.117
fatcat:jgen24jfszebjlzl3ortyy5jtq
The entrepreneurial marketing management and commercialization arrangements of born-global bio-enterprises: the case of UK companies
2014
Journal of Small Business and Entrepreneurship
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
industry. ...
Born global bio-enterprises are a unique "breed" of relatively small biotechnology enterprises operating in multiple countries. ...
This process involved the use of secondary data and empirical evidence obtained from each born global bio-enterprise. ...
doi:10.1080/08276331.2014.994696
fatcat:s3vgptjsozcxrpy553ww6zanii
« Previous
Showing results 1 — 15 out of 1,687 results